secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mereo BioPharma Group plc (MREO)
CIK:        0001719714
Form:       8-K
Filed at:   2024-05-23T23:59:59+00:00
Accession:  0001193125-24-145983
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

All seven proposals approved at Mereo BioPharma 2024 AGM; director re-elections pass with >91% support
--------------------------------------------------------------------------------

- Annual report adopted with 99.66% of votes cast in favor; PwC reappointed as auditor (99.60% support).
- Dr. Denise Scots-Knight re-elected as director (91.13% for), Dr. Jeremy Bender re-elected (92.46% for), Dr. Anders Ekblom re-elected (94.12% for).
- Directors' remuneration report approved with 98.63% of votes cast in favor.
- All votes based on 536,018,312 ordinary shares represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719714/000119312524145983/0001193125-24-145983-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719714/000119312524145983/d840193d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-145983

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer